e-learning
resources
Berlin 2008
Monday, 06.10.2008
Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
HRCT-score and markers of fibrosis in BAL in DPLD patients
A. Szlubowski, J. Soja, P. Grzanka, R. Tomaszewska, P. Kopinski, J. Kuzdzal, A. Cmiel, K. Sladek (Zakopane, Krakow, Bydgoszcz, Poland)
Source:
Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Session:
Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Session type:
Thematic Poster Session
Number:
1881
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Szlubowski, J. Soja, P. Grzanka, R. Tomaszewska, P. Kopinski, J. Kuzdzal, A. Cmiel, K. Sladek (Zakopane, Krakow, Bydgoszcz, Poland). HRCT-score and markers of fibrosis in BAL in DPLD patients. Eur Respir J 2008; 32: Suppl. 52, 1881
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
From pulmonary gas exchange to the interpretation of arterial blood gases
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
BALF proteomic analysis in polymyositis/dermatomyositis patients with interstitial lung disease
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Early detection of lung disease in cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
Neutrophil-rich inflammation in induced sputum of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001
The impact of age on broncholaveolar lavage (BAL) cytoimmunological results in nonsmoking patients with interstitial lung diseases (ILD) and in healthy volunteers
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
BAL markers of alveolar/capillary abnormality in IPF
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Source: Eur Respir J 2003; 22: 239-244
Year: 2003
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP.
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept